PRNewsWire - Health

Halozyme Therapeutics Added to Russell 1000® Index
APPLICATIONS OPEN FOR NEXT TEN N-SISS: FELLOWS
Nektar Therapeutics Announces Proposed Public Offering
Cancer Therapeutics Market Forecast to Reach $168 Billion by 2029, Highlighting Recurrent and Metastatic Innovations